105 related articles for article (PubMed ID: 25821228)
1. Reply to Thysen et al.
Tchakoute CT; Hesseling AC; Blakney AK; Jaspan HB
J Infect Dis; 2015 Oct; 212(8):1342-3. PubMed ID: 25821228
[No Abstract] [Full Text] [Related]
2. Changes in BCG Vaccination Policy Should Consider the Effect on Child Health.
Thysen SM; Aaby P; Benn CS; Fisker AB
J Infect Dis; 2015 Oct; 212(8):1341-2. PubMed ID: 25821229
[No Abstract] [Full Text] [Related]
3. Delayed BCG vaccination--time to take a shot.
Kay AW; Blish CA
J Infect Dis; 2015 Feb; 211(3):335-7. PubMed ID: 25108029
[No Abstract] [Full Text] [Related]
4. The safety and immunogenicity of an adenovirus type 35-vectored TB vaccine in HIV-infected, BCG-vaccinated adults with CD4(+) T cell counts >350 cells/mm(3).
Churchyard GJ; Snowden MA; Hokey D; Dheenadhayalan V; McClain JB; Douoguih M; Pau MG; Sadoff J; Landry B
Vaccine; 2015 Apr; 33(15):1890-6. PubMed ID: 25698492
[TBL] [Abstract][Full Text] [Related]
5. [Current advances in HIV pathogenesis. Results of therapy and vaccine development].
Wagner R; Mayer J; Wolf H
Dtsch Med Wochenschr; 1995 May; 120(20):728-36. PubMed ID: 7758413
[No Abstract] [Full Text] [Related]
6. [The infection and immunity of HIV: hope and thought].
Shang H
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(4):220-2. PubMed ID: 17425861
[No Abstract] [Full Text] [Related]
7. HIV as an inflammatory disease.
Smith D
J HIV Ther; 2009 Nov; 14(3):50-1. PubMed ID: 20218238
[No Abstract] [Full Text] [Related]
8. [Immunobiology of HIV infection].
Hattori T
Uirusu; 2002 Dec; 52(2):245-9. PubMed ID: 12685315
[No Abstract] [Full Text] [Related]
9. Cellular immune responses to HIV.
McMichael AJ; Rowland-Jones SL
Nature; 2001 Apr; 410(6831):980-7. PubMed ID: 11309628
[TBL] [Abstract][Full Text] [Related]
10. [Tuberculosis: molecular genetic BCG vaccine preparation].
Pneumologie; 1997 Aug; 51(8):XIV. PubMed ID: 9380655
[No Abstract] [Full Text] [Related]
11. Impaired Bacillus Calmette-Guérin cellular immune response in HIV-exposed, uninfected infants.
Mazzola TN; da Silva MT; Abramczuk BM; Moreno YM; Lima SC; Zorzeto TQ; Passeto AS; Vilela MM
AIDS; 2011 Nov; 25(17):2079-87. PubMed ID: 21866040
[TBL] [Abstract][Full Text] [Related]
12. T-cell repertoire and HIV infection: facts and perspectives.
Cossarizza A
AIDS; 1997 Jul; 11(9):1075-88. PubMed ID: 9233453
[No Abstract] [Full Text] [Related]
13. [CD8+ cell noncytotoxic antiviral response (CNAR) to HIV in nosocomial HIV-infected individuals].
Yuan L; Ma LY; Zang XH; Meng XD; Peng H; Zhao QB; Xing H; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):195-7. PubMed ID: 19031701
[TBL] [Abstract][Full Text] [Related]
14. The proliferative response of HIV+ T-cells (CD4+ and CD8+) are severely suppressed via CD28 coactivation.
Eylar EH; Báez I; Lefranc CE; Colón-Martínez SL; Rodríguez V; Yamamura Y; Rodriguez N
Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):989-93. PubMed ID: 9449531
[TBL] [Abstract][Full Text] [Related]
15. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection.
Betts MR; Ambrozak DR; Douek DC; Bonhoeffer S; Brenchley JM; Casazza JP; Koup RA; Picker LJ
J Virol; 2001 Dec; 75(24):11983-91. PubMed ID: 11711588
[TBL] [Abstract][Full Text] [Related]
16. Induction of prolonged survival of CD4+ T lymphocytes by intermittent IL-2 therapy in HIV-infected patients.
Kovacs JA; Lempicki RA; Sidorov IA; Adelsberger JW; Sereti I; Sachau W; Kelly G; Metcalf JA; Davey RT; Falloon J; Polis MA; Tavel J; Stevens R; Lambert L; Hosack DA; Bosche M; Issaq HJ; Fox SD; Leitman S; Baseler MW; Masur H; Di Mascio M; Dimitrov DS; Lane HC
J Clin Invest; 2005 Aug; 115(8):2139-48. PubMed ID: 16025158
[TBL] [Abstract][Full Text] [Related]
17. Vaccines. From Israel: a T-cell vaccine.
TreatmentUpdate; 2005; 17(1):11-2. PubMed ID: 17228460
[No Abstract] [Full Text] [Related]
18. Modelling the influence of activation-induced apoptosis of CD4+ and CD8+ T-cells on the immune system response of a HIV-infected patient.
Stan GB; Belmudes F; Fonteneau R; Zeggwagh F; Lefebvre MA; Michelet C; Ernst D
IET Syst Biol; 2008 Mar; 2(2):94-102. PubMed ID: 18397120
[TBL] [Abstract][Full Text] [Related]
19. Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery.
Singh KP; Howard JL; Wild SP; Jones SL; Hoy J; Lewin SR
Clin Immunol; 2007 Aug; 124(2):200-6. PubMed ID: 17574925
[TBL] [Abstract][Full Text] [Related]
20. The dynamics of CD4+ T-cell depletion in HIV disease.
McCune JM
Nature; 2001 Apr; 410(6831):974-9. PubMed ID: 11309627
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
